|
|
|
|
|
|
|
|
|
|
|
|
|
Here’s what you need to be aware of:
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
FDA Grants Orphan Drug Designation to Elixirgen’s Gene Therapy for Rare Disease
|
|
|
 |
|
|
|
Elixirgen Therapeutics, a clinical-stage biotech company, develops therapies to treat rare diseases. Its gene therapy, EXG-34217, is used to treat Telomere Biology Disorders.
|
|
|
|
|
|
|
|
|
|
|
Sandoz Launches Pyzchiva® in the US, Expanding Biosimilar Access
|
|
|
 |
|
|
|
Sandoz is a global leader in generic and biosimilar medicines. By officially launching Pyzchiva® in the US, it successfully expanded access to affordable biologic treatments.
|
|
|
|
|
|
|
|
|
|
|
Chugai’s Tecentriq® Receives Approval in Japan for Unresectable Alveolar Soft Part Sarcoma
|
|
|
 |
|
|
|
Chugai developed Tecentriq® to treat unresectable alveolar soft part sarcoma. It is the first immune checkpoint inhibitor available in Japan for this rare and aggressive cancer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Navigate the Digital Frontier with Pharma Now!
|
|
|
 |
|
|
|
Check the cover story
“SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
In this exclusive interview, she shares her bold career shift and lessons from managing 40,000+ employees across industries. Discover how she balances 7,000+ employees, keeps real connections alive in HR, and sustains a 100-year-old company’s culture.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Are you attending Pittcon 2025?
|
|
|
 |
|
|
|
Pittcon 2025 is set to take place in San Diego, CA, from March 1-5. This event combines scientific sessions, technical workshops, and poster presentations and caters to professionals in analytical chemistry, spectroscopy, and related fields.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
